CD73-IN-3
CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay) . CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research[1].
Product Specifications
CAS Number
[2375815-63-5]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cd73-in-3.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC([C@@H]1[C@](C(C=C(C(C(N2)=O)=CNC2=O)N=N3)=C3C)([H])C1)C
Molecular Formula
C15H18N4O2
Molecular Weight
286.33
Precautions
H315, H319
References & Citations
[1]Robert Dean Dally, et al. Cd73 inhibitors. Patent WO2019168744 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
